Life Science: Business Opportunities in the emerging markets
by Dr. Elisete Pedrollo - Berners Consulting Partner: Dr. Pedrollo Consulting
The Life Science market worldwide has also being impacted by the recession of the years 2008 - 2009, however following these years the industry leaders show confidence that the market is steadily recovering and the future looks promising. In 2012, the global Life Science market size was around $ 45 billion, but this number may vary depending on the segments that are taken into consideration. Included in this branch are the healthcare industry (pharmaceuticals, medical devices), the biotechnology (molecular diagnostics, vaccines, bioenergy) and the Contract Research Organizations (CROs), thus covers a very broad spectrum.
Different surveys show that the emerging markets (specially the BRICS countries) are the most profitable region for Life Science investors. Expansion on the emerging markets goes from forming alliances with pharma/biotech and medical devices companies, acquiring strategic business or establishing know-how transfer partnerships. Brazil and China are becoming highly attractive targets for foreign investment in the Life Science arena, since both countries have being investing heavily in their healthcare system to bring people under a primary medical insurance program. On top of that the number of consumers accessing the medical care and cosmetics products is exponentially growing.
Brazil and China have also recognized the needs and demand for better, higher quality medical equipment in order to become more competitive in the foreign markets. Just as an example the Brazilian medical devices industry has shown an astonishing growth of 51% in their export numbers (2012), showing that the Brazilian quality for health equipment is well accepted outside the country. The medical devices market in China achieved a record of 30% growth and reached the revenues of $ 21 Billion in 2011.
Because the Life Science market is being reshaped by patent expirations, healthcare reforms and new sources of competition, global companies are constantly looking for innovation to drive their further growth and success. Possible responses include exploring creative partnerships, new approaches to accessing emerging markets and developing strategic responses. Dr. Pedrollo Consulting and Berners Consulting are the right partners to support you at your expansion strategy in these exciting emerging markets.
For further information on the Brazilian Life Science market, please contact Dr. Elisete Pedrollo at epedrollo@berners-consulting.net.